CRYM.US Cryomass Technologies Inc
- Market cap
- USD 47.4K
- P/E
- -
- P/B
- 2.83x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2024.
Is CRYM.US undervalued?
Graham numberThe Graham number of Cryomass Technologies Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cryomass Technologies Inc fundamental analysis
No fundamental analysis for Cryomass Technologies Inc yet.
Cryomass Technologies Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cryomass Technologies Inc
Cryomass Technologies Inc., together with its subsidiaries, develops and licenses equipment to refine harvested cannabis, hemp trichomes, and other premium crops in the United States. It offers CryoSift Separator, which capture intact cannabis and hemp trichomes. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado.
Full company profileCryomass Technologies Inc financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cryomass Technologies Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 3.48M | 781K | 0.00 | 0.00 | 13.6K | 32.3K |
| Gross Profit | 0.00 | 0.00 | 1.04M | 37.2K | 0.00 | 0.00 | 13.6K | 32.3K |
| Operating Income | -51.9K | -337K | -3.02M | -6.53M | -7.99M | -10.3M | -5.94M | -4.02M |
| EBITDA | - | -387K | -2.87M | -6.62M | -7.90M | -10.1M | -12.2M | - |
| Net Income | -56.8K | -427K | -3.06M | -11.8M | -12.9M | -10.4M | -13.0M | -7.03M |
| EPS | 0.00 | -0.01 | -0.03 | -0.12 | -0.07 | -0.05 | -0.06 | -0.03 |
| Balance Sheet | ||||||||
| Total Assets | 107.00 | 704K | 16.1M | 7.80M | 15.6M | 7.86M | 973K | 1.13M |
| Total Liabilities | 177K | 57.0K | 2.34M | 4.19M | 2.06M | 3.29M | 6.82M | 10.6M |
| Shareholders' Equity | -177K | 647K | 13.7M | 3.61M | 13.5M | 4.57M | -5.85M | -9.44M |
| Cash & Short-term Investments | 107.00 | 207K | 3.47M | 330K | 5.77M | 2.02M | 49.2K | 183K |
| Cash Flow | ||||||||
| Operating Cash Flow | 98.00 | -492K | -1.80M | -3.75M | -5.60M | -4.77M | -3.80M | -727K |
| Capital Expenditure | 457K | 457K | 1.23M | 1.23M | 1.23M | 400K | 74.2K | 0.00 |
| Free Cash Flow | 98.00 | -909K | -1.83M | -3.75M | -5.83M | -5.17M | -3.88M | -865K |
| Ratios | ||||||||
| ROE | - | -66.1% | -22.3% | -327.7% | -95.1% | -227.8% | - | - |
| ROA | -53,050.5% | -60.8% | -19.0% | -151.5% | -82.5% | -132.6% | -1,332.2% | -622.8% |
| Net Profit Margin | - | - | -87.9% | -1,512.0% | - | - | -95,600.1% | -21,812.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Cryomass Technologies Inc dividends
Cryomass Technologies Inc has not paid dividends in the last 7 fiscal years.
Last stock split: 2:1 on Apr 26, 2018.
Who owns Cryomass Technologies Inc
- Insiders 15.72%
- Institutions 0.00%
- Public & others 84.28%
- Shares outstanding 237M
- Free float 229M
Cryomass Technologies Inc company profile
- Company name
- Cryomass Technologies Inc
- Ticker
- CRYM.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- 1001 Bannock Street, Denver, CO, United States, 80204
- Phone
- 303 416 7208
- Website
- cryomass.com
About Cryomass Technologies Inc
Cryomass Technologies Inc., together with its subsidiaries, develops and licenses equipment to refine harvested cannabis, hemp trichomes, and other premium crops in the United States. It offers CryoSift Separator, which capture intact cannabis and hemp trichomes. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado.
Cryomass Technologies Inc management
7- Mr. Christian NoelCEO & Director · born 1977
- Mr. Philip Blair Mullin B.A., M.B.A.Chief Financial Officer · born 1954
- Ms. Patricia I. KovacevicGeneral Counsel, Corporate Secretary & Head of External Affairs · born 1971
- Mr. Ryan SmithChief Operating Officer of Good Meds
- Mr. Stephen SchroederConsultant
- Ms. Caroline LenardonConsultant
- Ms. Janice MatthewsConsultant